INTERNATIONAL PATENT: LAEKNA THERAPEUTICS SHANGHAI CO., LTD. FILES APPLICATION FOR "ANTIBODIES THAT BIND TO ACVR2A AND ACVR2B AND USES THEREOF"

GENEVA, April 27 -- LAEKNA THERAPEUTICS SHANGHAI CO., LTD. (5th Floor, 987 Cailun Road, ZhangjiangPudong New Area, Shanghai 201203) filed a patent application (PCT/CN2025/127735) for "ANTIBODIES THAT BIND TO ACVR2A AND ACVR2B AND USES THEREOF" on Oct 15, 2025. With publication no. WO/2026/082057, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Ruipeng (5th Floor, 987 Cailun Road, ZhangjiangPudong New Area, Shanghai 201203), YANG, Mengxue (5th Floor, 987 Cailun Road, ZhangjiangPudong New Area, Shanghai 201203), CHEN...